Healthcare group, Stirling Products Limited (ASX:STI) advises that the Company has not proceeded with formalising the appointment of Mr Jeremy Cocks as the Company’s CEO following advice to the market last month of his conditional appointment.
The Company is in discussion with other parties with regard to this position and will advise the market accordingly.
The Company is continuing with its review of operations and has placed its O’Connell Street, Sydney properties on the market and will advise the market of further developments.
The Company also advises that it has commenced a process to seek a dual listing on the London Stock Exchange Alternative Investment Market (AIM) in order that the Company may benefit from the more extensive and in depth UK and European investment industry coverage of the pharmaceutical and healthcare industry.
For further information please download PDF below: